AQST CapEx to Revenue

Aquestive Therapeutics Inc · CapEx to Revenue

AQST logo

AQST CapEx to Revenue

Current (TTM)1.08%
AQST CapEx/Revenue (1.88% → 1.08%)
High-resolution chart · PNG

AQST capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Aquestive Therapeutics Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
1.2616%
0.2762%
1.9671%
5.2936%
1.7961%
1.1276%
1.2602%
2.705%
3.0903%
1.8847%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.